▶︎ Journal of Atherosclerosis and Thrombosis
——————————
Review
——————————-
Advancements in the Treatment of Homozygous Familial Hypercholesterolemia
Archna Bajaj and Marina Cuchel, J Atheroscler Thromb, 2022; 29: 1125-1135.
——————————
Editorials
——————————-
Association of a Body Shape Index as a Novel Anthropometric Indicator with Subclinical Atherosclerosis
Kazunori Otsui, J Atheroscler Thromb, 2022; 29: 1136-1137.
IGF-1 and Cardiovascular and Non-Cardiovascular Mortality Risk in Patients with Chronic Kidney Disease: A Model of “Malnutrition-Inflammation-Atherosclerosis Syndrome”
Michio Shimabukuro, J Atheroscler Thromb, 2022; 29: 1138-1139.
——————————
Original Articles
——————————
Association Between a Body Shape Index and Subclinical Carotid Atherosclerosis in Population Free of Cardiovascular and Cerebrovascular Diseases
Xiaotian Ma, et al., J Atheroscler Thromb, 2022; 29: 1140-1152.
Associations of Serum Insulin-Like Growth Factor 1 with New Cardiovascular Events and Subsequent Death in Hemodialysis Patients: The DREAM Cohort
Rino Nakaya, et al., J Atheroscler Thromb, 2022; 29: 1153-1165.
Height and Mortality from Aortic Aneurysm and Dissection
Midori Takada, et al., J Atheroscler Thromb, 2022; 29: 1166-1175.
Phenotypic and Genetic Analyses of Korean Patients with Familial Hypercholesterolemia: Results from the KFH Registry 2020
Hyoeun Kim, et al., J Atheroscler Thromb, 2022; 29: 1176-1187.
Relation of Serum Lipoprotein(a) Levels to Lipoprotein and Apolipoprotein Profiles and Atherosclerotic Diseases in Japanese Patients with Heterozygous Familial Hypercholesterolemia: Familial Hypercholesterolemia Expert Forum (FAME) Study
Ryo Naito, et al., J Atheroscler Thromb, 2022; 29: 1188-1200.
Familial Hypercholesterolemia in Patients with Acute Coronary Syndrome: Genetic Insights from EXPLORE-J
Mariko Harada-Shiba, et al., J Atheroscler Thromb, 2022; 29: 1201-1212.
Real-World Analyses of the Safety Outcome among a General Population Treated with Statins: An Asian Population-Based Study
Jia-Ling Lin, et al., J Atheroscler Thromb, 2022; 29: 1213-1225.
Atherogenic Index of Plasma and the Risk of In-Stent Restenosis in Patients with Acute Coronary Syndrome beyond the Traditional Risk Factors
Yong Zhu, et al., J Atheroscler Thromb, 2022; 29: 1226-1235.
Practical Assessment of the Tradeoff between Fatal Bleeding and Coronary Thrombotic Risks using the Academic Research Consortium for High Bleeding Risk Criteria
KYohei Sotomi, et al., J Atheroscler Thromb, 2022; 29: 1236-1248.
Association between Multimorbidity and Kidney Function among Patients with Non-Dialysis-Dependent CKD
Shigeru Tanaka, et al., J Atheroscler Thromb, 2022; 29: 1249-1264.